CVS says the use of ear cytology in OE is beneficial, both as a diagnostic and to evaluate the response to therapy.
However, in 2019 the company looked at 26,269 of its patients and found that ear cytology was only being used in 19.2% of cases, in line with the rest of the profession.
Only 11% of cases were being provided with in-house point-of-care cytology, whilst 8.2% had it performed externally.
80.8% of patients with OE were being prescribed antibiotics without cytological support, with 5% of these the highest priority critically important antibiotics (HPCIAs).
This low level of cytology use in primary care was suspected to be a major contributory factor to the significant use of unnecessary antibiotics.
To support its practices, CVS first looked at the barriers to performing ear cytology interventions, which were identified as a lack of confidence in using the microscope (particularly focusing on x100 and identification of pathological events), a perceived lack of time, insufficient or poorly working equipment, a lack of access to equipment, and the perception that cytology does not change the treatment choice or outcome.
As a second step, a minimal list of cytology equipment was developed to ensure that all sites had the right kit.
New equipment was then supplied to a practice if it did not meet minimum standards.
The company then produced education and resource materials, including new guidelines, imagery and video guides, to upskill both its vets and nurses.
The training focused on: equipment maintenance, cleaning and troubleshooting, how to use the microscope – including x100 magnification and the slide oil immersion technique, how to identify pathological changes, and time management to get a consultation done – including swabbing, microscope analysis, diagnosis and client consultation.
Each site was then provided with its own data, so that it could monitor progress.
Elizabeth McLennan Green, CVS Clinical Director for the North, said: “One of our goals with this project was to minimise the number of antibiotics prescribed without associated diagnostics, and to use ear cytology to guide therapy and response to treatment for the benefit of our patients and clients.”
“We know that low ear cytology interventions are an issue across the profession. We wanted to do better. So ear cytology has been our first and longest running clinical improvement project.
"We’re thrilled with the brilliant results our colleagues are now achieving.”
There's a video presentation about the project here: https://vimeo.com/875515008/bdc3ee5920
Photo: Emily Spencer, Head Vet at Castle Vets
The device emits low dose 265 nanometre (nm) ultraviolet C light at a targeted area.
In a 2022 in vitro / ex vivo study to evaluate the therapeutic potential of 265nm UVC for infectious keratitis1, UVC was found to inhibit all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance.
In the study, no evidence of infection was found from 4 hours onwards, ulcers responded significantly in under 24 hours, and at the end point, those treated with UVC performed as as well as those treated with ciprofloxacin.
Photon Therapeutics says that in simple cases, one five-second treatment will suffice, but more complex cases can be re-treated after 24 hours.
Currently, there are two main barriers to the successful treatment of eye infections in dogs.
The first is the difficulty diagnosing the infection and identifying the right antimicrobial to use, highlighted by a 2017 study: Bacterial Isolates from Canine External Ocular Disease and their Antimicrobial Sensitivities 2.
The second is whether the owner is able or willing to administer a topical treatment.
Here the evidence suggests that even when treatment is possible, people do not comply with clinical advice anything like as much as they claim.
Photon Therapeutics points to what it says is the nearest study there is, in which carers of young children with uveitis did not give the correct treatment in 75% of cases3.
If the device is as effective as claimed, then both these issues simply evaporate.
PhotonUVC costs £4,995.
https://photon-therapeutics.com
VetSurgeon.org product briefing: https://www.vetsurgeon.org/m/veterinary-product-briefing/138134
References
The National Office of Animal Health (NOAH) has launched a new 'Use Medicines Responsibly' campaign.
The main thrust of the campaign is an initiative by NOAH to encourage pharmaceutical companies to add: 'Use Medicines Responsibly' as a strapline to their own advertising campaigns, with a link to the NOAH information resource for prescribers and users of animal medicines: www.noah.co.uk/responsible.
Speaking at the NOAH annual members' conference in Northampton, NOAH chief executive Phil Sketchley said: "NOAH believes responsible promotion of animal medicines to be an important link in the chain towards responsible use. Companies' promotional material can educate prescribers and users of animal medicines to the benefit of their animals' health and welfare.
"We believe this new advice resource, with the reminder on advertisements, will help."
Intervet/Schering-Plough Animal Health has announced that it is re-introducing Equilis StrepE, the only strangles vaccine for horses in Europe. The vaccine was voluntarily withdrawn from the market in 2007 for stability reasons.
Equilis StrepE, which has already been relaunched in the Netherlands, is now scheduled to arrive in Italy in September and the United Kingdom in October this year. Further re-launches in European countries are scheduled later in 2010 and beyond.
According to Intervet/Schering-Plough, three years of additional research and development have resulted in several improvements to the vaccine, including a better manufacturing process to ensure that the product maintains its characteristics throughout its shelf-life. A more user-friendly applicator has been developed, which enables the needle to slot into place, thereby making it easier to administer the vaccine.
Equilis StrepE is administered through a submucosal injection in the upper lip of the horse and provides immunity for three months following two initial injections, four weeks apart. The vaccine significantly reduces clinical signs of strangles and occurrence of lymph node abscesses in horses that are at risk of infection.
Dr. Peter Daels, veterinarian at the Keros Insemination and Embryo Transfer Center in Beselare (Belgium) said: "In our recipient embryo transfer herd, we have used this strangles vaccine on over 500 mares. After a few applications, the vaccine was easy to administer and did not cause any serious side effects. Despite a steady flow of new horses, only eight cases of strangles were noted - all were mild and most were newly acquired horses that had apparently been exposed shortly before vaccination. I believe that the vaccine provided solid protection against the disease, reduced the severity of clinical cases and eliminated the risk of a widespread outbreak in our herd."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering Plough Animal Health said: "The re-launch of Equilis StrepE in Europe is an important milestone in our efforts to fully meet the needs of our customers in the equine industry. We continue to work in a very intense and comprehensive way to ensure adequate supply of our equine vaccine range".
The new ISFM Academy of Feline Practitioners is a body of dedicated veterinary surgeons from all over the world who have further qualifications in feline practice or medicine, or have specialised in disciplines that complement the focus of ISFM.
Members will have the opportunity to discuss publications, investigate cases with colleagues, collaborate on research, talk about developments, and forge links between themselves. The charity says it will be a forward-thinking coalition that will actively seek to advance developments in medicine. Any vet that meets the requirements of the academy can join.
To complement the veterinary expertise in the Academy of Feline Practitioners, the charity has also developed the iCatCare Feline Wellbeing Panel. The panel is an international coalition of experts who come from different professional backgrounds but who all specialise in some form in the mental wellbeing of cats.
The purpose of the panel is to help those working and caring for cats in all the various settings to understand their behavioural, emotional and cognitive capabilities and needs in order to be able to promote their mental wellbeing and ultimately protect their welfare.
Such settings include people’s homes, in catteries, in veterinary clinics, and in homing centres and on the streets. Through the sharing of initiatives and information in a confidential space, iCatCare says this will be a collaborative effort that will advance the accepted understanding and common practices in a way that would be impossible to do individually.
CEO, Claire Bessant (pictured right) said: "By working together, gaining input from great people and enabling all those who work with cats to grow their expertise, iCatCare can deliver on its mission to create a world in which each cat’s life experience will be as good as it can be’. For more information about how to join the ISFM Academy of Feline Practitioners, visit: https://icatcare.org/veterinary/isfm/isfm-academy. For more information about the Feline Wellbeing Panel, visit: https://icatcare.org/about/our-expert-panel
The VetCT teleconsulting service, which can be accessed via the web and an app-based platform, provides advice from a specialist team.
Typically advice is provided as a written report within 24 hours, with options for text chat or telephone conversations when vets may want to discuss the case with a specialist.
The service can be accessed on a pay-per-case or subscription basis.
Until now, follow-up advice had been capped at two weeks.
Internal medicine specialist and Head of Teleconsulting at VetCT, Kate Murphy, said: “We are delighted to be extending our support for cases that require ongoing management, such as endocrine disorders or complex wound management.
"Our clients have fed back how valuable it will be to partner with us longer term for these patients, to provide guidance and reassurance that care is being optimised and help to keep owners engaged and happy.”
welcome.vet-ct.com/sales
Mars says that during a typical anaesthetic procedure, less than five percent of the volatile anaesthetic agent delivered to a patient is absorbed and metabolised and about 95% is exhaled.
SageTech’s gas-capture technology – which is currently used in human healthcare – works by capturing the waste anaesthetic agent exhaled during an operation by adsorbing it into a reusable capture canister.
These waste anaesthetic agents can then be extracted from the filter, without incinerating or release them into the atmosphere.
Ellie West, RCVS and EBVS® European Specialist in Veterinary Anaesthesia and Analgesia, and Linnaeus Environmental Sustainability Lead, said: “As a leading provider of veterinary care, we have a responsibility to take climate action at scale and lead the way toward more sustainable practices.
“Our innovative collaboration should help us take a significant step forward in our sustainability journey, aimed at contributing to a better future for the planet – and the people and pets who depend on it.”
The one-year pilot will start with 10 Linnaeus primary care and referral veterinary practices in the UK, after which Mars says it plans to explore the potential application of this technology across other parts of its business.
https://www.sagetechveterinary.com
The RCVS has released the results of a competition held at BSAVA Congress earlier this month, in which veterinary surgeons, veterinary nurses and other members of the practice team were asked to identify three animals from sound only.
The correct answers were a purring cat, a Chihuahua dog (the breed had to be specified) and a guinea pig.
Of 370 entrants, only 104 (28%) were correct. Some of the more outlandish answers included, for the cat noise: elephant, lion, whale and dolphin; and, for the guinea pig noise: ferret, meerkat, dove, chicken and frog. However, the majority of those getting it wrong were stumped by the requirement to specify the breed of dog, with Jack Russell Terrier or some 'yappy little thing ' proving a favourite.
The winner of the competition was Liverpool-based veterinary surgeon, Anna Rowntree, who won an iPod Nano. She said: "I thought the competition was good fun and a real novelty. It certainly drew me to the stand and was not what I would have expected from the RCVS - it proves they can be approachable! I was very excited to have won and I still can't believe I have."
The noises competition linked to the College's theme for the event, 'Falling on deaf ears?', which examined how the organisation takes account of responses to its consultations, debunking the myth that those who take the trouble to reply are not listened to. The topic was addressed by President Professor Sandy Trees in a presentation on the Saturday of Congress. Visitors to the stand were also given RCVS-branded earphones to reinforce the listening message.
Copies of all three presentations made by the RCVS at BSAVA Congress are now available on RCVSonline (www.rcvs.org.uk/ear_ear). They are:
Ceva Animal Health has launched a new TV advertising campaign to raise awareness of the benefits of the veterinary behavioural product, Feliway.
The new advertisement, features the new 'Feliway' purple cat playing happily in the home with its family.
The advertisement will appear on the major UK channels including More 4, E4, ITV 1, Sky Channels and the Discovery Channel for one week from 16th September 2013, with an additional three weeks coverage during October 2013. Behind the scenes' footage of the filming of the advertisement can also be viewed on the Feliway YouTube Channel: http://www.youtube.com/channel/UCtAXd5mReYc6JGufxRirvng?feature=watch
A Feliway video on demand and YouTube campaign will be available to viewers between 16th September 2013 and 21st October 2013 and will be repeated between 15th November 2013 and 2nd December 2013.
An Adaptil video on demand campaign will be aired between 21st October 2013 and 11th November 2013 to raise awareness of Adaptil in the run up to and during the firework season. The video on demand will be available across ITV player, Sky Anytime On Demand, 4oD and YouTube.
For more information, call 01494 781510 or contact your local Ceva territory manager.
The scheme uses a traffic light colour system of vaccination reminder stickers which veterinary surgeons can place on the front of passports at each vaccination appointment. If the 6-month pilot is a success, the initiative will be rolled out across the UK in the summer.
BEVA says that despite the best efforts of numerous equine welfare charities to address the obesity issue, a significant proportion of owners are either not recognising obesity in their horses, or not being motivated to take action.
For this reason, the Association decided to try and confront the problem in a different way, using knowledge gained from the Behavioural Insights Team (BIT) – a government think tank specialising in behavioural economics and psychology.
Lucy Grieve, President Elect of BEVA and part of the Association’s obesity campaign working group, said: "Determined to look at new ways to positively engage with horse owners, we harnessed the BIT’s experience of what methods work most effectively and came up with a simple, practical scheme revolving around vaccination visits, which could be affected by vets themselves."
The idea is to use the routine annual or six-monthly vaccination visit as a time to assess a horse’s body condition. After the vaccination is given and the body condition assessed, a colour-coded vaccination reminder is stuck to the front of the passport, both to remind the owner when the next vaccination is due and to start a conversation about body condition.
A green sticker indicates a ‘healthy’ body condition. Amber means the horse is carrying too much fat tissue and needs moderate changes to diet, exercise, management, rugging and clipping regimes. Red implies that the horse is carrying excessive amounts of fat tissue which are placing the horse in morbid danger.
Amber or red stickers provide the opportunity to talk about the potential impact on the horse’s health and what needs to be done.
If there isn't enough time to talk about it during the appointment, the sticker includes a colour-specific QR code which the owner can use to access additional information via their smartphone in their own time.
One of three short, colour-specific videos will explain the reason their horse has been designated the colour of sticker on their passport, leading to a link to more specific advice on what the owner needs to do next. Having swotted up on the background information beforehand, the owner can then discuss the various management options with their vet at a convenient time.
Lucy said: "The first challenge is helping owners recognise when their horse is overweight. Once this has been established then we can make a plan to correct the problem as a team.
"The owner needs to be on board and committed in order to carry out the tough task of reducing the weight of their horse. We hope that owners will be ‘nudged’ by the sticker intervention to consider the information they have been offered and start to tackle the problem before it causes life-threatening disease."
Nine equine veterinary practices were invited to participate in the pilot scheme, including Loch Leven Equine Practice in Kinross. Managing director Liz Somerville said: "We have been focusing on equine obesity for the last couple of years including running a #FitnotFat campaign last year to try to highlight the growing obesity problem in our horses. Unfortunately, it sometimes feels that we are banging our heads against a brick wall so when BEVA came up with a new approach to try and get the message through to our owners it was too good an opportunity to miss."
BEVA says that at the end of the pilot, it will assess how well the project has worked for the vets involved, what proportion of owners used the QR codes, visited the advice pages and sought guidance from their vets.
For more information, visit: https://www.beva.org.uk/Resources-For-Vets-Practices/Clinical-Practice-Guidance/Obesity-in-horses
Norbrook has announced the launch of Spotinor Deltamethrin spot-on, a new product which kills a wide range of external parasites that can have economically damaging effects on cattle, sheep and lambs.
The product is effective against lice and flies on cattle, ticks, lice, keds and established blowfly strike on sheep, and lice and ticks on lambs. It is available in 250ml and 500ml squeeze neck dispensing packs as well as a 1 litre and 2.5 litre backpack with dosing gun. The dose is 10ml for cattle, 5ml for sheep and 2.5ml for lambs (under 10kg/1 month of age).
Spotinor has a zero milk withhold time.
Edward Haughey, Director of Norbrook GB, said: "As Britain's leading veterinary pharmaceutical company, Norbrook is committed to providing British farmers and vets with the products and services they need to manage animal health effectively. Spotinor is the first generic to market, which displays the same benefits as the pioneer product. We are delighted to launch Spotinor, which gives livestock producers a greater choice of safe and sound solutions for the control of external parasites."
For more information, contact your Norbrook representative, telephone +44 (0) 1536 741 147 or email: enquiries@norbrook.co.uk
The company says it believes it is the first major veterinary business in the UK to make this promise.
As a result of the pledge, salaries for about a third of the pet emergency firm's 1280 employees, including receptionists and animal care assistants, are set to increase to at least £9.50 an hour from April.
Vets Now says it has made the pledge on the recommendation of the Living Wage Foundation, which offers independent advice to employers and says £9.30 is now the real cost of living, not the Government-set national living wage of £8.72 for people aged 25 and over.
Vets Now’s chief executive Mark Ross said: "Our people are our biggest asset and at the heart of everything we do. We want to properly recognise the vital role each and every one of them plays in the business.
"This move demonstrates our commitment to that. We are confident that by paying all of our staff a competitive hourly rate of at least 20p more than the real living wage we will achieve higher morale and lower turnover."
Animal care assistant, Jody Reynolds, who works in Vets Now out-of-hours clinic in Kirkcaldy, said: “It’s amazing that Vets Now has been able to increase salaries to not only meet but exceed the real living wage. The extra will really help towards the cost of everyday living and even allow a few luxuries."
To meet market demands and ensure that their customers comply with regulatory requirements, British manufacturer Labcold has released the first models in a new range of vaccine and pharmaceutical refrigerators designed specifically for this use from the ground-up. The company says more models will be added to the range over the next 12 months.
When storing temperature-sensitive vaccines and pharmaceuticals, Veterinary Practices need to ensure compliance with an ever-increasing burden of legislation, regulations and guidelines, such as the latest VMD Code of Practice, (Oct 2007). The BVA Good Practice Guide - Standard Operating Procedure 04 on the storage of medicinal products in permanent premises says as follows:
Refrigerated storage must:
Although this guidance stops short of specifically excluding the use of domestic refrigerators, Labcold says professional products are more appropriate since they are built specifically for vaccine and pharmaceutical storage. Labcold refrigerators all fully compliant and have locking doors plus a host of handy options including capacity, glass doors and a new divided-drawer system.
Robin Gregson, Sales & Marketing Director at Labcold said, "Our whole product range is constantly being updated to ensure that we provide our customers with market-leading solutions. Many previous pharmacy refrigerators have simply been modified designs of domestic fridges, whilst our new range, the result of three years work, is one of the few on the market to be designed specifically for pharmacy use from the ground up."
For full information on all Labcold products, including portable refrigerators suitable for farm vets please visit http://www.labcold.com/ or contact sales@labcold.com / Telephone 0870 3001001 for a free copy of the latest Product Guide.
The Royal Veterinary College has opened a new specialist ophthalmologist service at the Queen Mother Hospital for Animals (QMHA) in Hertfordshire.
According to the College, the service is equipped with the most up-to-date and state-of-the-art equipment available and will also benefit from the on-hand support of leading edge veterinary care at Europe's largest small animal hospital.
The RVC says all ophthalmology cases will be supported by dedicated anesthesiologists, whilst on an individual case basis the ophthalmologists will draw upon the expertise of specialists in imaging, oncology, neurology, emergency and critical care, internal medicine, dermatology, soft tissue and orthopedic surgery.
The following services will be available to all species on referral:
Rick F. Sanchez, who heads up the new service, holds a Diploma from the European College of Veterinary Ophthalmologists (DipECVO) and is currently the only Ophthalmology Diploma holder working in a UK university. In his new role Rick will be sharing his expertise gained from the 3 years intensive specialist training and 7 years in dedicated specialty practice with both undergraduate and postgraduate students at the college in a teaching role alongside his clinical and research responsibilities.
Rick said: "Returning to academia has been the realization of a long held professional dream and to do so by becoming part of the Royal Veterinary College has been a privilege and an honour. The superb team of specialists and dedicated nurses already established at the RVC creates a perfect environment to exercise clinical excellence and offer our animal patients the very best care we strive to provide as specialists.
"In addition, I see the creation of the new Ophthalmology Service as the final piece of the puzzle within the wide array of clinical expertise offered at QMHA. In my opinion it is this wide array of expertise that makes the QMHA at the RVC a leading centre for clinical, teaching and research excellence in veterinary medicine in the UK."
For more information please visit: http://www.rvc.ac.uk/QMH/Specialities/Ophthalmology.cfm
Axiom Veterinary Laboratories is launching MiLab, a new range of in-practice analysers at the BSAVA Congress.
Axiom says the range will be supported with a comprehensive range of additional services, from installation and training through to technical support and maintenance.
Martyn Carpenter, Managing Director of Axiom Veterinary Laboratories said: "An increasing number of UK veterinary practices are opting to carry out a higher proportion of laboratory testing in-house but, in order to do this successfully, they need equipment which is reliable, cost-effective and easy-to-use. Two products in the MiLab range will be showcased at BSAVA, both of which have been selected following extensive validation and correlation testing in Axiom's veterinary laboratories."
The two new products are:
Martyn said: "Investing in significant new equipment is always challenging for practices and we have spoken to many over the last 18 months to understand their experience of and current requirements for in-house analysis and, in particular, the level of support they receive. Practices working with us can be confident that we are offering the very latest in analyser technology, which has been tested rigorously for reliability, economy and ease of use. They can also feel secure in the knowledge that we provide a high level of service and support, delivered by our own highly skilled laboratory technicians."
For more information, contact Steve Clarke at Axiom on 01626 357756.
Petplan has announced the winners of its annual Veterinary Awards.
The awards recognise and celebrate staff and practices throughout the country who have delivered an exceptional level of care, going above and beyond the call of duty in keeping the nation's pets healthy and owners happy.
Suzanne Cheadle, Petplan's Acting Head of Marketing said: "As the leader in the pet insurance market for over 36 years, we have a rich history of working with veterinary practices across the UK. The Petplan Veterinary Awards recognise and celebrate the fantastic work that goes on across those practices."
She added: "This year saw over 12,000 nominations which demonstrates the appetite from both staff and clients for celebrating exceptional work. We had a wonderful selection of first class finalists and I'd like to congratulate all the winners who thoroughly deserve their awards."
The winners for each category are:
VET OF THE YEAR: Hector Low, Old Mill Veterinary Practice, Isle-of-LewisThe judges said: "What really stood out was Hector's dedication to the profession and how he moved his practice to a new premises so it could offer better facilities and a wider range of services for animals and owners alike. He has always got his clients and their pets at the forefront of all his decisions and is truly passionate about his role within the profession". VET NURSE OF THE YEAR: Tina Wright, Warbeck House Veterinary Centre, MerseysideThe judges said: "Tina is particularly responsible for setting up an Ear Care Club for animals at the centre who suffer from recurrent ear problems, which she has put her heart and soul into over the last year, while also tutoring student veterinary nurses and running puppy socialisation classes which have proved hugely popular among clients. Tina is a shining example of how vital the role of the vet nurse is when delivering outstanding service to clients and their pets. She is enthusiastic, passionate and always puts her clients' needs first". PRACTICE SUPPORT STAFF OF THE YEAR: Henrietta Fidler, Beech House Veterinary Centre, SurreyThe judges said: "Henrietta is somebody who loves her role within the veterinary profession, thriving on the interaction she has between both the clients and animals. She has nurtured and developed strong and solid client relationships as well as good working relationships with her colleagues. If there is anything that the Veterinary Awards highlights, it is that team work is a vital part of the job, and Henrietta is proof of that". PRACTICE OF THE YEAR: The Vets' Place, CheshireThe judges saiod: "Wendy and Michael Hough set up their practice, The Vets' Place, from scratch in 2009. Since then, the practice has grown from strength to strength. As a small practice they have plenty of opportunity to really get to know their individual clients and their pets and have built strong relationships that their customers value. The Vet's Place is a shining example of the exceptional service a practice can deliver". PRACTICE MANAGER OF THE YEAR: Sharon Lane-Kieltyka, Shepton Veterinary Group Ltd, SomersetThe judges said: "Sharon is a people person through and through which feeds the passion she has for a role that extends beyond the care of clients and their pets. Sharon has overseen a large scale building project that saw the practice double in size and been a key driver in the recent rebranding of the practice, highlighting not only her steadfast can-do attitude, but her ability to drive change in the interest of her clients. Her enthusiasm for the industry is something to be admired".
Merial Animal Health has revealed the latest MOO test figures which suggest that the productivity of four out of five UK dairy herds is compromised by high levels of gutworm.
The company says it has been helping dairy farmers to assess the level of gutworm challenge in their herds since 2009 by supporting and promoting MOO tests. The test measures the level of antibody to gutworm (Ostertagia ostertagii) that is present in a bulk milk sample and can determine if the herd has been exposed to low, medium or high challenge.
Data from five years of MOO tests shows that whilst there was a steady reduction in the number of herds with a high challenge between 2009 and 2013, the figure rose in 2014. In 2009, 93% of herds tested high and by 2013 this had fallen to 71% but this rose again to 88% last year.
Merial says that whilst these figures show an overall reduction in challenge since 2009, levels of gutworm across the UK dairy herd are still very high. Those animals affected will suffer from the negative impact of a parasite burden on productivity and fertility.
Between 2009 and 2014 nearly 900 dairy herds across the UK have been tested. During that time several counties had significant numbers of herds with high gutworm challenge results. This included Cheshire (85%), Cornwall (93%), Cumbria (91%), Dyfed (92%), Lancashire (90%), North Yorkshire (83%), Shropshire (86%), Somerset (86%), and Staffordshire (83%).
Sioned Timothy, veterinary adviser for Merial Animal Health, said: “Gutworm can significantly reduce the productivity of the herd. Although adult dairy cows develop immunity to gutworm that makes them resilient to outward clinical signs of infection, it does not prevent them from becoming infected with Ostertagia ostertagi. This parasite burden can reduce milk yield by as much as 2.6 litres per cow per day1”
She continued: “Gutworm may also have a negative impact on fertility. Removing damaging gutworms from dairy cows may improve their fertility and has been linked to reduced calving to conception intervals and improved conception rates2 to levels comparable with animals without a gutworm burden.
"Calving is another key period in the production cycle. Optimising cow and heifer management during this period is critical to the animal’s health and productivity throughout the subsequent lactation. Cows treated for gutworms around the time of calving have been shown to increase their grazing time by almost an hour compared to untreated cows3. Improved appetite and higher dry matter intake helps cows to bridge the energy gap; maximising their production, and reducing the time it takes to get them back into calf4.”
The MOO test figures show that the UK dairy herd continues to be affected by high levels of gutworm challenge. At a time when maximising productivity is vital to dairy business success, farmers should seriously consider testing their herd this autumn and develop a treatment plan with their vet or animal health adviser based on the result.”
MOO tests will be available in autumn 2015. The results of MOO tests are sent to both the farmer and their vet or animal health advisor, to enable them to determine the best course of action and treatment.References1 Reist et al, Effect of eprinomectin treatment on milk yield and quality in dairy cows in South Tyrol, Italy. Veterinary Record 2011 168, 484-487 Vet Rec 2002151:377-3802 McPherson et al. Proceedings of the American Association of Veterinary Parasitologists. 44th Annual Meeting, New Orleans, Louisiana, USA, 1999 Abstr. 28.3 Forbes et al. Behavioural mechanisms underlying production responses in dairy cows treated with eprinomectin. 19th WAAVP Congress 2003, New Orleans4 Sanchez et al. The effect of eprinomectin treatment at calving on reproduction parameters in adult dairy cows in Canada. Preventative Veterinary Medicine 2002 56:165-177
Lucy Chadwick, Head of Technical Services & Marketing at Forte Healthcare Ltd said: “Neonatal calf diarrhoea is a leading cause of death in the calf crop in the UK and Ireland.
"We are delighted to therefore offer this webinar discussing up to date information on what we can do to boost neonatal defences in the face of an NCD outbreak.
"Tune in to learn more about the importance of colostral antibodies and how the resecretion of antibodies plays a key role in gut protection.
"We will also discuss what factors can influence the effectiveness of a NCD vaccination programme and what this means for your farmers.”
You'll be able to ask questions during the event and the webinar will also be made available to watch on demand afterwards.
https://www.thewebinarvet.com/pages/forte-healthcare-register
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Reference
The VET Festival has announced its speaker line-up for this year's event, taking place on the 3rd & 4th June at Loseley Park in Guildford, Surrey.
The 21 hand-picked speakers include respected opinion formers from across the USA, Canada and the UK who are veterinary specialists and experts in fields including clinical & surgical orthopaedics, soft tissue surgery, medical & surgical oncology, neurology & neurosurgery, minimally invasive surgery & diagnostics, anaesthesia, diagnostic imaging, physiotherapy, sports medicine & rehabilitation, anaesthesia & critical care, nutrition, feline medicine & surgery and practice management & team building.
The organisers say this is a unique and unrivalled opportunity to hear, learn and network with some of the greatest minds in the veterinary world at a dynamic and engaging two-day outdoor conference designed for veterinary surgeons, veterinary nurses, veterinary rehab practitioners, practice support staff, managers and allied veterinary professionals working in companion animal practice.
Internationally-based speakers not available on the usual speaker circuit for primary care clinicians, include:
The 2016 conference will also welcome thought leaders currently practicing here in the UK, including:
There will be a focus on minimally invasive diagnostics and surgery lead by Phillip Mayhew from the University of Davis California and Elise Robertson will talk about minimally invasive endoscopy techniques in cats whilst Michael Kowaleski from Tufts University, Boston, and Noel Fitzpatrick will talk about arthroscopy of joints. There will also be a specific focus on diagnostic imaging with Russell Tucker from Washington State University sharing his nearly 40 years of experience with radiography, MRI and CT. Cancer is a huge area of increased interest in small animal practice currently and will be explored by a world-class team including Julius Liptak, Nick Bacon and Laurent Findji.
The growing importance of practice management and team-building prompted organisers to ask Brian Faulkner from the UK and Ernie Ward from the USA, both internationally recognised leaders in veterinary business training, to set up a mini-symposium in management and motivation. The objective is to keep the lectures practical and give delegates information that they can use every day, not just facts and figures.
Unlike conventional conferences, the VET Festival is staged outdoors in marquees alongside festival food and drinks and companies and organisations showcasing new technologies and products. Organisers say that this unique ‘fresh air’ festival environment creates a relaxed and fun atmosphere which is more conducive to learning and networking. There will be live music on both nights of the Festival with multiple bands contributing to the festival atmosphere, culminating in the ONE LIVE music concert on the final night.
For more information and to register for an early bird delegate discount visit www.vetfestival.co.uk
Zoetis has announced that a batch of the bluetongue vaccines, Zulvac® 8 Bovis and Zulvac® 8 Ovis, is expected to become available to veterinary practices in mid-July, in time to manage the risk of an outbreak predicted by Defra to reach mainland UK by the late summer.
The company says the quantity of vaccine will not be unlimited and that it will strive to achieve as widespread availability as possible.
The two vaccines (Bovis for cattle and Ovis for sheep) are licensed to “prevent viraemia” caused by bluetongue virus serotype 8 (BTV-8). Prevention of viraemia, the presence of bluetongue virus in the blood, ensures no onward spread of infection via the blood sucking Culicoides midge.
The vaccines can be used in cattle from three months of age, or six weeks in sheep, requiring two doses three weeks apart in either species. Each dose is 2ml administered intramuscularly in cattle or subcutaneously in sheep, and onset of immunity is 25 days after the second dose. The vaccine provides immunity for a full 12 months.
The British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement from Zoetis, and another from MSD, but sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control. While it is good news that vaccine will be available, we know that both farmers and vets will have questions about cost and whether there will a limit to the amount of vaccine available in July. It would be helpful to have these questions clarified as soon as possible."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
The new resources include the Equine Veterinary Journal’s (EVJ) publication of BEVA’s Primary Clinical Care Guidelines on wound management in horses together with BEVA’s first ever digital CPD course: 'How to Heal Wounds – a masterclass for vets and vet nurses'.
The new guidelines cover three key areas: wound lavage and topical treatments; wound debridement and closure and therapeutics for wound healing.
Sarah Freeman, who led the project, said: "These guidelines are aimed at the vast majority of our membership who are primary care practitioners. Topics covered are voted for by BEVA’s panel of specialists and represent a benchmark in time against the strength and weakness of evidence that support it."
The wound management guidelines follow BEVA’s recommendations on the safe use of analgesia in horses, which were published earlier this year.
BEVA’s new online course: 'How to Heal Wounds' is aimed at mixed and equine practitioners and veterinary nurses who encounter wounds in horses.
Led by Dr Patrick Pollock BVMS, PhD, CertES(Soft Tissue), DipECVS, FHEA, FRCVS along with teaching from leading names including Professor Derek Knottenbelt OBE, BVM&S, DVM&S, DipECEIM, MRCVS, Dr Dylan Gorvy BSc, BVSc, PhD, CertES(Soft Tissue), DipECVS, and Ms Georgie Hollis BSc it will provide key concepts of wound physiology and introduce new treatment ideas and modalities designed to optimise wound healing.
Tim Mair Chair from BEVA’s Education Committee said: “This course is an absolute masterclass for vets and vet nurses. It contains 12 on-demand recorded lectures, together with the opportunity to attend up to three live discussions with the speakers. The final live discussion will provide the opportunity for the delegates to trouble shoot with our speakers after being able to go and practice the skills and knowledge learnt on the course.”
The course will be available from August 2020. It will cost £65 for BEVA members (£130 for non-members), which includes access to course resources for up to a year – meaning if they can’t attend a live discussion, they can watch it later.
Photo: Dr G Quinn.
The company highlights figures which show that about 170,000 of calves born alive each year die in their first month of life1 and that up to 50% of deaths are caused by scour2, with over 48% of dairy heifer calves diagnosed with scour preweaning3. ORT, says the company, could help save the industry £60 million a year1.
The new campaign will encourage farmers to use ORT during scouring to provide sufficient essential electrolytes to correct acidosis, while still continuing with milk feeding. The company says milk is the best source of energy and fluid replacement for scouring calves and stopping milk has been shown to have no impact on the resolution of scour. In fact, calves left on milk during scour can continue to gain weight. The Making Milk Matter Against Scour initiative is being backed by a PR and advertising campaign and a social media initiative.
During the campaign Ceva will be running surveys to capture both vets’ and farmers’ experiences of scour and ORT. To take part in the vet survey visit https://www.surveymonkey.co.uk/r/ORTVet. There will be a prize draw from completed entries, with 10 vets receiving a £10 Amazon voucher.
Stephenie Clarke, product manager at Ceva Animal Health said: "The ‘Making Milk Matter Against Scour’ campaign will help highlight the financial and welfare benefits of using ORT at the first signs of scour and the importance of administering it alongside milk which is the best source of energy and will help calves maintain weight gain.
"The scour survey will provide us with an insight into the use of ORT in practice and on farm to help us drive improvements across the industry."
James Adams, BVSc FHEA MRCVS, farm animal lead at Langford Vets, University of Bristol, added: “If I could offer one piece of advice to farmers with scouring animals it would be to ensure hydration as dehydration is what kills! Rehydrating an animal is essential if an animal is to be able to regain its normal function and fend off any disease.
"We’ve been using Rehydion in our vet practice for approximately two years and we mainly recommend that farmers use it in cattle, but our clients also use it in lambs and kids. We get a lot of positive feedback from farmers on Rehydion, as they feel that it is effective and convenient to use, which aids compliance, and it can be given with milk, which is essential for maintaining a positive energy status."
For further information on the ‘Making Milk Matter Against Scour’ initiative visit www.makingmilkmatter.co.uk, contact your local Ceva Account Manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
Biogal’s CEO, Mr Amos Gershony said: "We placed a large effort behind creating these videos, so that our customers could visualize how simple it is to receive a PCR result in 1 hour."
The videos are: